January 18, 2018
Immunotherapy 101: Your Questions Answered
Few breakthroughs in battling cancer have generated more excitement recently than immunotherapy. It’s helping some patients—including high profile ones like former president Jimmy Carter—achieve long-term remission and possibly even a cure when their cancer... read more
October 11, 2017
Trial Helps Determine Optimal Dose of Next-Generation Drug for Acute M...
Jean-Pierre Issa, MD, former director of the Fels Institute for Cancer Research and Molecular Biology at the Lewis Katz School of Medicine, Temple University, recently published the results of a phase 2 study comparing the safety and efficacy of two... read more
April 27, 2017
Patients Needed for New Multiple Myeloma Study
In addition to excellent clinical care, Fox Chase Cancer Center is home to a team of world-renowned cancer researchers who develop and test therapies not available anywhere else. For more than a century, Fox Chase has been a key contributor in advancing... read more
March 13, 2017
A New Phase 1 Clinical Trial for Non-Small Cell Lung Cancer
As a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, Fox Chase Cancer Center offers our patients the most advanced treatment options through clinical trials, many of which are not readily available elsewhere. Our nationally ranked... read more
February 10, 2017
A New Stage 4 Clinical Trial for Colorectal Cancer
As a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, Fox Chase Cancer Center offers our patients the most advanced treatment options through clinical trials, many of which are not readily available elsewhere. Our nationally ranked... read more
January 18, 2017
A New Stage 2-4 Clinical Trial for HIV-associated Hodgkin Lymphoma
As a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, Fox Chase Cancer Center offers our patients the most advanced treatment options through clinical trials, many of which are not readily available elsewhere. Our nationally ranked... read more